Regarding Severe-Death hematologic cancer patients, we observed a chemokine axis involving CCL2, CCL3, CXCL8 and IL-6, and an inverse correlation between IL-1β and monocytes (Figure 7C), indicating that those patients displayed an exacerbated inflammatory response as compared to patients that recovered from COVID-19. The gene discussed is CCL3; the disease is hematopoietic and lymphoid cell neoplasm.